Beth Reed

Principal Analyst, Research

Beth manages Healthcare Business Insights’ Revenue Cycle Scorecard and revenue cycle data. Her day-to-day focus is on surveying in all areas of the healthcare provider revenue cycle, data analysis, and Scorecard customization. She has extensive experience researching business office topics, such as claims submission and follow-up, denials, self-pay collections, payer relations, and vendor management. Beth joined Healthcare Business Insights in 2014.

arrow_forwardDownload bio

Contact our experts

Hear @DrNandiQ explain how foundations of #trust in the integrity of research is being built and strengthened within the scientific community on our #ClarivatePodcast. https://clarivate.com/podcasts/ideas-to-innovation-season-two/the-future-of-research-integrity/

#Innovation #I2I

Career Tip >> Want to get noticed by recruiters? Try incorporating SEO techniques into your resume and application.

Learn how at https://clarivate.com/blog/want-to-work-at-clarivate-five-tips-for-todays-job-seeker/.

Meet Clarivate >> Robert Poolman oversees our @ClarivateHealth product team. Outside of work, Robert loves #running, #biking and #camping with his family.

Discover the importance of #LifeatClarivate at https://careers.clarivate.com/creative/lifeatclarivate/.

#InternationalDayofPeace >> Find out how how #research is contributing to #SDG16 and bringing to light key issues like mass incarceration and racial #health inequity. Learn more on our blog: https://clarivate.com/blog/highly-cited-papers-in-sdg-16-peace-justice-and-strong-institutions/

NEWS >> 20 world-class #researchers were named #CitationLaureates using #publication and #citation data from the #WebofScience.

See who made this year’s list: https://clarivate.com/news/clarivate-reveals-citation-laureates-2022-annual-list-of-researchers-of-nobel-class/?campaignname=Citation_Laureates_SAR_Global_2022&campaignid=7014N000001YaCc&utm_campaign=Citation_Laureates_SAR_Global_2022&utm_source=twitter&utm_medium=social

.@IUBloomington Distinguished Professor. @Clarivate Citation Laureate. David Audretsch is described many ways, but he takes the most pride in one label: Teacher. “I love this part of life where people are..trying to find their path in life..it's a privilege to be part of that.”

Creating trust in scientific #research begins with research integrity. Hear @DrNandiQ explain how shared responsibility across all stakeholders can build a solid foundation on our #ClarivatePodcast: https://clarivate.com/podcasts/ideas-to-innovation-season-two/the-future-of-research-integrity/

#Innovation #I2I

Dr. Eugene Garfield established the Institute for Scientific Information in 1960 to provide products and services covering the literature of the sciences, social sciences and humanities. Find out how his legacy has evolved at https://clarivate.com/the-institute-for-scientific-information/.

We are pleased that @DrNandiQ, Editor-in-Chief & Editorial VP of the #WebofScience, has been elected to the @STMAssoc board. Nandita is a leader in transforming #publishing practices, an #OA advocate and a former scientific #researcher: https://www.stm-assoc.org/people/nandita-quaderi/.

Dr. Grace Lomax developed technologies like #PatientConnect to work collaboratively with #physicians and #pharmacists to support #patients unmet needs.

Learn how her experiences shaped her career: https://clarivate.com/podcasts/ideas-to-innovation-season-two/sustainability-leadership-in-pharma/

#I2I #ClarivatePodcast

Contact us

Investors

Careers

Login

Beth Reed

Principal Analyst, Research

Life Sciences and Healthcare

Latest news

BioWorld by Clarivate Adds Laser-focused Preclinical Research News into New Fully Integrated Platform

BioWorld by Clarivate Explores the Concept of Extending Human Lifespan in New Report

Clarivate Healthcare Business Insights Announces 2021 Revenue Cycle Awards Recipients

Related resources

Real Knowledge, Artificial Intelligence: How to Ensure You Have Enough of Both in your Organization

Improving patient access and healthcare literacy [PODCAST]

Shorter timelines, evolving strategies: Four key trends in regulatory approvals of new medicines

Subscribe to our news